Location: Amsterdam
Synced from ClinicalTrials.gov · August 07, 2026
Clinical studies recruiting near Amsterdam
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
Transcranial Magnetic Stimulation to Slow Down Cognitive Decline in Alzheimer's Disease NA · Amsterdam UMC · Willem de Haan · NCT07036328 Assessment of the Alignment of the Atlas and Surrounding Tissues in Chronic Whiplash Associated Disorder Phase N/A · Amsterdam UMC · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT06413667 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract Phase 3 · Amsterdam UMC, locatie VUmc · Eli Lilly and Company · NCT07218380 Single-dose Preoperative Partial Breast Irradiation in Low-risk Breast Cancer Patients NA · Amsterdam UMC · Amsterdam UMC, location VUmc · NCT05350722 A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients Wit Phase 1 · Amsterdam UMC Stichting · eleva GmbH · NCT07483827 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Phase 2/Phase 3 · Local Institution - 0033 · Bristol-Myers Squibb · NCT07106762 Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features Phase 2/Phase 3 · Amsterdam University Medical Center · Leiden University Medical Center · NCT05255653 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients Phase 2 · Amsterdam Universitaire Medische Centra (UMC) - locatie Amst · Miltenyi Biomedicine GmbH · NCT04844866 Immune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer (TNBC) Pa Phase 2 · Antoni van Leeuwenhoek · The Netherlands Cancer Institute · NCT04159818 A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors Phase 1 · The Netherlands Cancer Institute · Seagen, a wholly owned subsidiary of Pfizer · NCT05208762 The DRAGON 2 Trial NA · Amsterdam UMC, location AMC · Maastricht University · NCT05428735 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease Phase 2 · Amsterdam UMC Locatie AMC · Boehringer Ingelheim · NCT07355296 Induction Treatment for Initially Unresectable Colorectal Liver Metastases: Combined Hepatic Arterial Infusion Pump Ther Phase 3 · Antoni van Leeuwenhoek-Netherland Cancer Institute · The Netherlands Cancer Institute · NCT06857773 Screening for Malnutrition in Obese Patients Phase N/A · OLVG · HAN University of Applied Sciences · NCT06626360 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop Phase 3 · NKI The Netherlands Cancer Institute · Hoffmann-La Roche · NCT06793215 UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease Phase N/A · Emma Children's Hospital, Amsterdam UMC · The Hospital for Sick Children · NCT06560606 Metabolic Heterogeneity Underlying Hypertriglyceridemia: Hepatic Triglyceride Biosynthesis in Humans With Different Insu NA · AMC Amsterdam · Yale University · NCT05743868 Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies Phase 3 · Academisch Medisch Centrum (Amsterdam UMC) · Lakefront Biotherapeutics NV · NCT06652633 Rituximab Induced Remission in Patients With Chronic Inflammatory Demyelinating Polyneuropathy Phase 3 · Amsterdam UMC · Amsterdam University Medical Center (UMC), Location Academic · NCT06714838 Skeletal Muscle Mitochondria in Ageing Phase N/A · Vrije Universiteit Amsterdam · VU University of Amsterdam · NCT06539078 Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for Glabellar Rhytides Phase 4 · Faceland · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT06448676 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov Phase 3 · Onze Lieve Vrouwe Gasthuis · Amgen · NCT07037433 Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Ag Phase 1 · Amsterdam UMC, Location VUmc /ID# 267670 · AbbVie · NCT06896916 A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advance Phase 1/Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT06885034 Postoperative Basal Bolus or Sliding Scale Insulin Regimen in DM2 and Its Effect on Surgical Site Infections. NA · Amsterdam UMC · Abraham Hulst, MD, PhD · NCT06638567 A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies Phase 1/Phase 2 · Antonie Van Leeuwenhoek Hospital · Deciphera Pharmaceuticals, LLC · NCT05957367 Immune-supportive Diet and Gut Permeability in Allergic Children NA · OLVG · Onze Lieve Vrouwe Gasthuis · NCT05667610 Prasugrel Monotherapy Reduced Dose in Acute and Chronic Coronary Syndrome Patients After Percutaneous Coronary Intervent Phase 4 · Amsterdam UMC · J.P.S Henriques · NCT06916520 The Radium-select Study NA · NKI-AVL · The Netherlands Cancer Institute · NCT06659926 A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Sele NA · Amsterdam UMC · Alimentiv Inc. · NCT07363044
Look up another city
Look up another condition